Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 6/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | APP | P05067 | 1/20 | 0.30 |
| ▸ | BCHE | P06276 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16787283 | 0.97 | SIGMAR1 (0.33) | SIGMAR1KDM4ECYP1A2CYP3A4CYP2D6 | |
| SCHEMBL16787267 | 0.86 | SIGMAR1 (0.34) | SIGMAR1L3MBTL1 | |
| SCHEMBL16787329 | 0.85 | GPR84 (0.30) | — | |
| SCHEMBL16787262 | 0.85 | SIGMAR1 (0.32) | SIGMAR1 | |
| SCHEMBL16786681 | 0.85 | SIGMAR1 (0.32) | SIGMAR1 | |
| SCHEMBL10135972 | 0.84 | SIGMAR1 (0.42) | SIGMAR1KDM4ECYP1A2CYP3A4CYP2D6 | |
| SCHEMBL16305504 | 0.84 | SIGMAR1 (0.42) | SIGMAR1KDM4ECYP1A2CYP3A4CYP2D6 | |
| SCHEMBL16385672 | 0.84 | SIGMAR1 (0.42) | SIGMAR1KDM4ECYP1A2CYP3A4CYP2D6 | |
| SCHEMBL16305507 | 0.84 | SIGMAR1 (0.42) | SIGMAR1KDM4ECYP1A2CYP3A4CYP2D6 | |
| SCHEMBL29776726 | 0.84 | SIGMAR1 (0.42) | SIGMAR1KDM4ECYP1A2CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150162542-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE | SAMSUNG SDI CO., LTD. (KR) | 2015-06-11 | — | — | US | disclosed |
| US-20150162542-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE | SAMSUNG SDI CO., LTD. (KR) | 2015-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150162542-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE | AOX1, ODC1, OR51E2 | SIGMAR1 794/4885KDM4E 2058/4885CYP1A2 268/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.